ArticleThe clinical respiratory journal2024

Clinical Management in NSCLC Patients With EGFR Mutation After Osimertinib Progression With Unknown Resistance Mechanisms.

Xin Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.